Viral Fusion Protein Inhibitors
"Viral Fusion Protein Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that are designed to block the action of VIRAL FUSION PROTEINS and prevent VIRUSES from entering the cell.
| Descriptor ID |
D065147
|
| MeSH Number(s) |
D27.505.519.957 D27.505.954.122.388.538
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Viral Fusion Protein Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Viral Fusion Protein Inhibitors".
This graph shows the total number of publications written about "Viral Fusion Protein Inhibitors" by people in this website by year, and whether "Viral Fusion Protein Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2015 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 2 | 0 | 2 |
| 2018 | 2 | 0 | 2 |
| 2019 | 1 | 0 | 1 |
| 2020 | 2 | 1 | 3 |
| 2021 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Viral Fusion Protein Inhibitors" by people in Profiles.
-
Intranasal fusion inhibitory lipopeptide prevents direct-contact SARS-CoV-2 transmission in ferrets. Science. 2021 03 26; 371(6536):1379-1382.
-
Pan-coronavirus fusion inhibitors as the hope for today and tomorrow. Protein Cell. 2021 02; 12(2):84-88.
-
Micro-fusion inhibition tests: quantifying antibody neutralization of virus-mediated cell-cell fusion. J Gen Virol. 2021 01; 102(1).
-
Broad-Spectrum Coronavirus Fusion Inhibitors to Combat COVID-19 and Other Emerging Coronavirus Diseases. Int J Mol Sci. 2020 May 28; 21(11).
-
Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein. Cell Mol Immunol. 2020 07; 17(7):765-767.
-
A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike. Sci Adv. 2019 04; 5(4):eaav4580.
-
Chemical array system, a platform to identify novel hepatitis B virus entry inhibitors targeting sodium taurocholate cotransporting polypeptide. Sci Rep. 2018 02 09; 8(1):2769.
-
Peptide-Based Membrane Fusion Inhibitors Targeting HCoV-229E Spike Protein HR1 and HR2 Domains. Int J Mol Sci. 2018 Feb 06; 19(2).
-
Therapeutic efficacy of a respiratory syncytial virus fusion inhibitor. Nat Commun. 2017 08 01; 8(1):167.
-
Is maraviroc useful in multiple sclerosis patients with natalizumab-related progressive multifocal leukoencephalopathy? J Neurol Sci. 2017 Jul 15; 378:233-237.